UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

Pharmacokinetic–pharmacodynamic modeling to study the anti-dysmenorrhea effect of Guizhi Fuling capsule on primary dysmenorrhea rats

Phytomedicine (Stuttgart), 2018-09, Vol.48, p.141-151

2018

Volltextzugriff (PDF)

Rhamnetin Attenuates Melanogenesis by Suppressing Oxidative Stress and Pro-inflammatory Mediators

Biological and Pharmaceutical Bulletin, 2013/08/01, Vol.36(8), pp.1341-1347

Kim, You Jung

2013

Volltextzugriff (PDF)

Effects of an aqueous extract of Crataegus pinnatifida Bge. var. major N.E.Br. fruit on experimental atherosclerosis in rats

Journal of ethnopharmacology, 2013-07, Vol.148 (2), p.563-569

2013

Volltextzugriff (PDF)

Gastric-sparing nitric oxide-releasable 'true' prodrugs of aspirin and naproxen

Bioorganic & medicinal chemistry letters, 2014-12, Vol.24 (24), p.5587-5592

2014

Volltextzugriff (PDF)

Panax quinquefolium saponin combined with dual antiplatelet drugs inhibits platelet adhesion to injured HUVECs via PI3K/AKT and COX pathways

Journal of ethnopharmacology, 2016-11, Vol.192, p.10-19

2016

Volltextzugriff (PDF)

Des-Arg9-bradykinin causes kinin B1 receptor mediated endothelium-independent contractions in endotoxin-treated porcine coronary arteries

Pharmacological research, 2014-12, Vol.90, p.18-24

2014

Volltextzugriff (PDF)

Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression

European journal of pharmacology, 2009-10, Vol.620 (1), p.112-119

2009

Volltextzugriff (PDF)

COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: An in vitro analysis

Pharmacological research, 2005-10, Vol.52 (4), p.302-306

2005

Volltextzugriff (PDF)

Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation

Journal of veterinary pharmacology and therapeutics, 2012-02, Vol.35 (1), p.19-32

2012

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of three formulations of firocoxib in healthy horses

Journal of veterinary pharmacology and therapeutics, 2015-06, Vol.38 (3), p.249-256

2015

Volltextzugriff (PDF)

Chinese herbal medicinal ingredients inhibit secretion of IL-6, IL-8, E-selectin and TXB2 in LPS-induced rat intestinal microvascular endothelial cells

Immunopharmacology and immunotoxicology, 2009-12, Vol.31 (4), p.550-555

2009

Volltextzugriff (PDF)

Narghile (water pipe) smoking influences platelet function and (iso-)eicosanoids

Life sciences (1973), 2003-11, Vol.74 (1), p.47-53

2003

Volltextzugriff (PDF)

Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization

British journal of pharmacology, 2007-09, Vol.152 (1), p.73-82

2007

Volltextzugriff (PDF)

Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2

British journal of pharmacology, 2005-02, Vol.144 (4), p.538-550

2005

Volltextzugriff (PDF)

Comparative Impact on Prostanoid Biosynthesis of Celecoxib and the Novel Nonsteroidal Anti-Inflammatory Drug CG100649

Clinical pharmacology and therapeutics, 2012-06, Vol.91 (6), p.986-993

2012

Volltextzugriff (PDF)

A CAPE analogue as novel antiplatelet agent efficiently inhibits collagen-induced platelet aggregation

Pharmazie, 2014-08, Vol.69 (8), p.615-620

2014

Volltextzugriff (PDF)

Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016)

The Journal of pharmacology and experimental therapeutics, 2005-12, Vol.315 (3), p.1331

2005

Volltextzugriff (PDF)

Nitric oxide and prostacyclin pathways: An integrated mechanism that limits myocardial infarction progression in anaesthetized rats

Pharmacological research, 2006-04, Vol.53 (4), p.359-366

2006

Volltextzugriff (PDF)

Lumiracoxib Does Not Affect the Ex Vivo Antiplatelet Aggregation Activity of Low-Dose Aspirin in Healthy Subjects

Journal of clinical pharmacology, 2005-10, Vol.45 (10), p.1172-1178

2005

Volltextzugriff (PDF)

Covalent Modification of Cyclooxygenase-2 (COX-2) by 2-Acetoxyphenyl Alkyl Sulfides, a New Class of Selective COX-2 Inactivators

Journal of medicinal chemistry, 1998-11, Vol.41 (24), p.4800-4818

1998

Volltextzugriff (PDF)

In Vitro Effects of Clopidogrel on the Platelet-Subendothelium Interaction, Platelet Thromboxane and Endothelial Prostacyclin Production, and Nitric Oxide Synthesis

Journal of cardiovascular pharmacology, 2004-01, Vol.43 (1), p.74-82

2004

Volltextzugriff (PDF)

2′-Ethoxy-5′-Methoxy-2-(5-Methylthienyl)Chalcone Inhibits Collagen-Induced Protein Tyrosine Phosphorylation and Thromboxane Formation during Platelet Aggregation and Adhesion

Pharmacology, 2009-01, Vol.84 (3), p.145-152

2009

Volltextzugriff (PDF)

NCX4016 (NO‐Aspirin) has multiple inhibitory effects in LPS‐stimulated human monocytes

British journal of pharmacology, 2001-10, Vol.134 (4), p.905-911

2001

Volltextzugriff (PDF)

NCX4016 (NO‐aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs

British journal of pharmacology, 2002-04, Vol.135 (8), p.1882-1888

2002

Volltextzugriff (PDF)

In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production

European journal of pharmacology, 2001-06, Vol.422 (1-3), p.209-216

2001

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect_期刊（NSTL购买）

Zeitschrift / SerieThrombosis Research

ThemaThromboxane B2 - Analogs & Derivatives

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(106)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(106)
Science & Technology
(106)
Animals
(79)
Male
(62)
Biological And Medical Sciences
(56)
Medical Sciences
(46)
Humans
(42)
Pharmacology. Drug Treatments
(41)
Thromboxane B2 - Blood
(39)
Rats
(33)
Thromboxane B2 - Biosynthesis
(33)
Thromboxane B2 - Metabolism
(31)
Platelet Aggregation - Drug Effects
(30)
Blood Platelets - Metabolism
(26)
Female
(25)
Blood Platelets - Drug Effects
(24)
In Vitro Techniques
(24)
Platelet Aggregation Inhibitors - Pharmacology
(23)
Dose-Response Relationship, Drug
(18)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetic–pharmacodynamic modeling to study the anti-dysmenorrhea effect of Guizhi Fuling capsule on primary dysmenorrhea rats

Rhamnetin Attenuates Melanogenesis by Suppressing Oxidative Stress and Pro-inflammatory Mediators

Effects of an aqueous extract of Crataegus pinnatifida Bge. var. major N.E.Br. fruit on experimental atherosclerosis in rats

Gastric-sparing nitric oxide-releasable 'true' prodrugs of aspirin and naproxen

Panax quinquefolium saponin combined with dual antiplatelet drugs inhibits platelet adhesion to injured HUVECs via PI3K/AKT and COX pathways

Des-Arg9-bradykinin causes kinin B1 receptor mediated endothelium-independent contractions in endotoxin-treated porcine coronary arteries

Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression

COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: An in vitro analysis

Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation

Pharmacokinetics and pharmacodynamics of three formulations of firocoxib in healthy horses

Chinese herbal medicinal ingredients inhibit secretion of IL-6, IL-8, E-selectin and TXB2 in LPS-induced rat intestinal microvascular endothelial cells

Narghile (water pipe) smoking influences platelet function and (iso-)eicosanoids

Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization

Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2

Comparative Impact on Prostanoid Biosynthesis of Celecoxib and the Novel Nonsteroidal Anti-Inflammatory Drug CG100649

A CAPE analogue as novel antiplatelet agent efficiently inhibits collagen-induced platelet aggregation

Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016)

Nitric oxide and prostacyclin pathways: An integrated mechanism that limits myocardial infarction progression in anaesthetized rats

Lumiracoxib Does Not Affect the Ex Vivo Antiplatelet Aggregation Activity of Low-Dose Aspirin in Healthy Subjects

Covalent Modification of Cyclooxygenase-2 (COX-2) by 2-Acetoxyphenyl Alkyl Sulfides, a New Class of Selective COX-2 Inactivators

In Vitro Effects of Clopidogrel on the Platelet-Subendothelium Interaction, Platelet Thromboxane and Endothelial Prostacyclin Production, and Nitric Oxide Synthesis

2′-Ethoxy-5′-Methoxy-2-(5-Methylthienyl)Chalcone Inhibits Collagen-Induced Protein Tyrosine Phosphorylation and Thromboxane Formation during Platelet Aggregation and Adhesion

NCX4016 (NO‐Aspirin) has multiple inhibitory effects in LPS‐stimulated human monocytes

NCX4016 (NO‐aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs

In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production

Aktive Filter

Suchergebnisse filtern